Ali Yildizbakan

Ali Yildizbakan

Auto-generated profile, based on publicly available information

Ali Yildizbakan

Department of Obstetrics and Gynecology, Department of Gynecologic Oncology, Osmaniye State Hospital Osmaniye Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2025 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
GÜGörkem ÜLGER
Görkem ÜLGER
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
KAKasim AKAY
Kasim AKAY
HYHAMZA YILDIZ
HAMZA YILDIZ
AYAli Yildizbakan
Ali Yildizbakan
HAHakan Aytan
Hakan Aytan
The coexistence of adenomyosis and cancer of the endometrium has attracted heightened scrutiny, leading to inquiries regarding their possible interactions and clinical ramifications. This study sought to assess the influence of adenomyosis on tumor features and survival outcomes in patients with endometrioid-type endometrial carcinoma. A retrospective cohort analysis was performed on 422 patients who underwent surgical intervention for endometrioid-type endometrial carcinoma. The cohort was categorized into two groups according to the presence or absence of adenomyosis. Clinical and pathological data were gathered and evaluated to compare tumor features and survival outcomes between the two cohorts. Adenomyosis was present in 144 (34.1%) patients. Patients in the adenomyosis group demonstrated significantly higher gravidity and parity compared to those without adenomyosis. Lymphovascular space invasion was detected in 8.3% of the adenomyosis group compared to 17.6% in the non-adenomyosis group (a 53% reduction, p = 0.010). Similarly, rates of myometrial invasion (81.3% vs. 65.5%, p = 0.001), cervical stromal invasion (9.0% vs. 14.1%, p = 0.005), and lymph node metastasis (4.2% vs. 14.4%, p = 0.001) were significantly lower in patients with adenomyosis. The five-year overall survival rate was 90.8% in the adenomyosis group and 87.1% in the non-adenomyosis group, although this difference was not statistically significant (p = 0.689). This study demonstrates that adenomyosis is associated with a significant reduction in aggressive tumor characteristics such as myometrial invasion, lymphovascular space involvement, and lymph node metastasis in patients with endometrioid-type endometrial cancer. These findings emphasize that adenomyosis may be a potential protective factor in endometrial cancer prognosis and should be considered in clinical risk assessment. Prospective studies with larger cohorts are needed to confirm the long-term effects of adenomyosis on survival.

24 October 2025 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
GÜGörkem ÜLGER
Görkem ÜLGER
HYHAMZA YILDIZ
HAMZA YILDIZ
KAKasim AKAY
Kasim AKAY
AYAli Yildizbakan
Ali Yildizbakan
PAPelin Aytan
Pelin Aytan
HAHakan Aytan
Hakan Aytan

19 May 2024 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Verified
Journal Article
Closed access
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
Mürşide ÇEVİKOĞLU KILLIMürşide ÇEVİKOĞLU KILLI
Mürşide ÇEVİKOĞLU KILLI
AYAli Yıldızbakan
Ali Yıldızbakan
GÜGörkem ÜLGER
Görkem ÜLGER
TITolgay Tuyan İlhan
Tolgay Tuyan İlhan
Amaç: İleri evre over malignitelerinde cerrahi sonrası morbidite nedenlerini, hastanede yatışla ilişkili risk faktörlerini değerlendirmek. Gereçler ve Yöntem: Eylül 2018–Aralık 2023 tarihleri arasında Mersin Üniversitesi Jinekolojik Onkoloji Bilim Dalı’na başvuran evre III over malignitesi tanısı olan 88 hasta çalışmaya dahil edildi. Hastaların demografik bilgileri, kanserin histolojik tipleri, tedavinin yönetimi ve sitoredüktif cerrahinin kapsamı, komplikasyonlar ve yönetimi, yoğun bakım ihtiyacı, morbidite ve erken dönem yatış süreleri, hastaneye yeniden kabuller ve müdahaleler değerlendirilmiştir. Bulgular: Primer sitoredüktif cerrahi (PSC) sonrası hastaların %70.6’sında, nüks sonrası cerrahilerin %74.1’inde, neoadjuvan kemoterapi sonrası interval sitoredüksiyon (NAKS-IS) yapılan hastaların %70.4’ünde komplet sitoredüksiyon sağlandı. Postoperatif erken dönemde morbiditenin en sık nedenleri sırası ile %17 yara yeri enfeksiyonu, %10.2 atelektazi, bulantı-ileus %9.1 idi. Yara yeri enfeksiyonu, atelektazi, ileus, tromboemboli görülme sıklığı açısından istatistiki olarak guruplar arası fark yoktu(p=0.537). Postoperatif dönemde yatış süresi ve 2. basamak yoğun bakım ihtiyacı açısından yönetimler arası fark yoktu(p>0.05). Postoperatif hospitalizasyonun en sık nedeni yara yeri enfeksiyonudur. Sonuç: Tedavi yönetimlerimiz arasında ve sitoredüksiyon başarıları açısından fark yoktu(p>0.05). NAKS-IS’in PSC’ye göre cerrahi süresi, yoğun bakım ihtiyacı, hastanede kalış süresi bakımından avantajlı bulunmuştur. Sitoredüksiyon oranları ve postoperatif komplikasyonlar açısından fark bulunmamıştır(p>0.05). Yara yeri enfeksiyonunun NAKS-IS te PSC’ye oranla fazla olma nedenini NAK bağlı sitopeni ile ilişkilendirebiliriz. PSC’de NAKS-IS’e kıyasla hızlı patoloji kullanımı, ameliyat süresi, postoperatif atelektazi ve ileus oranları artmıştır. Sitoredüktif cerrahi sonrası yara yeri enfeksiyonu, atelektazi, ileus ve tromboemboli açısından hastaların yakın takibi önemlidir.

30 September 2024 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Verified
Journal Article
Closed access
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
TITolgay Tuyan İlHan
Tolgay Tuyan İlHan
GÜGörkem ÜLGER
Görkem ÜLGER
AYAli Yıldızbakan
Ali Yıldızbakan
Mürşide ÇEVİKOĞLU KILLIMürşide ÇEVİKOĞLU KILLI
Mürşide ÇEVİKOĞLU KILLI
HYHAMZA YILDIZ
HAMZA YILDIZ
Aim: The objective of our study was to evaluate the preoperative circumstances, treatments, and postoperative states of patients at our university hospital. Materials and Methods: This retrospective study used the Mersin University Hospital's gynecological oncology clinic database. Patient age, menopausal status, preoperative tumor markers, and preoperative ultrasonography features were collected from the hospital databases. After the initial procedure, information regarding the surgical method, histological classification, stage at the time of diagnosis, size of the tumor, status of the lymph nodes, and the ultimate pathological diagnosis were collected. Results: This study has a cohort of 84 patients who underwent surgery between 2007 and 2023. The study groups had a median age of 41.5, ranging from 15 to 88. Out of the total patients, 71.4% were in the premenopausal stage. Final pathology revealed the presence of a malignant tumor in 10 patients, accounting for 11.9% of the total. Out of the total number of patients, six had serous tumors, while four had mucinous tumors. Out of the 83 people, a recurrence of the condition was found in 3, indicating a rate of 3.6%. The mean duration of progression-free survival for these individuals was 19 months. Only individuals in the early stage of the disease experienced a recurrence, and two exhibited micropapillary variants. Conclusion: Ultimately, BOTs have a highly favorable prognosis. Patients who meet the criteria might consider undergoing fertility-preserving surgical procedures.